Omnicell, Inc. (NasdaqGS: OMCL)
Health Care · Health Care Equipment & Supplies · US
$34.66
-2.59% today · +4.7% 1Y
Omnicell, Inc. (NasdaqGS: OMCL) operates in the Health Care Equipment & Supplies industry within the Health Care sector. The company is valued at $1.58B and employs 3,485 people.
Over the last twelve months the share price has gained 4.7%, trading between 29.06 and 55.00.
Tweenvest scores Omnicell, Inc. across four factors: quality 76/100, value 72/100, growth 55/100. Its strongest factor is quality.
OMCL price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $1.58B
- Revenue (TTM)
- $1.25B
- P/E
- 41.19
- EPS
- 0.84
- Dividend yield
- —
- Beta (5Y)
- 0.97
- 52-week high
- $55.00
- 52-week low
- $29.06
- Avg volume (3M)
- —
- Shares outstanding
- 45.61M
- Employees
- 3,485
- Next earnings
- —
About Omnicell, Inc.
Omnicell, Inc., together with its subsidiaries, provides healthcare technology in the United States and internationally. It offers hospital and health systems solutions, such as points of care for clinician workflows in patient care areas of the healthcare system; Titan XT, an automated dispensing system; XTExtend, a console swap for its XT cabinets; and Central Pharmacy Dispensing Service for the medication dispensing process. The company also provides Central Med Automation Service for medication dispensing; IV Compounding Service, an in-house compounding system; specialty pharmacy services, including turnkey solution to help health systems establish, manage, and optimize an entity-owned specialty pharmacy; EnlivenHealth platform to digitally enable retail and community pharmacies; medication adherence solutions comprising consumables and medication packaging systems; and technology implementation, customer education and training, program management, and related offerings to professional services. In addition, it offers post-installation support and maintenance via phone and/or web, on-site service, parts, and access to software upgrades; software and hardware products for full traceability of medicines and medical supplies throughout the healthcare system; OmniSphere, a cloud-based platform. The company was formerly known as Omnicell Technologies, Inc. and changed its name to Omnicell, Inc. in 2001. Omnicell, Inc. was incorporated in 1992 and is headquartered in Fort Worth, Texas.
- ISIN
- US68213N1090
- Founded
- 1992
- Listed since
- Aug 7, 2001
- Exchange
- Nasdaq Global Select
- Currency
- USD
Other Health Care Equipment & Supplies companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Abbott LaboratoriesNYSE: ABT | $201.88B | $116.43 | -0.21% |
| Intuitive Surgical, Inc.NasdaqGS: ISRG | $131.97B | $375.01 | +0.39% |
| Stryker CorporationNYSE: SYK | $125.74B | $326.66 | -0.35% |
| Medtronic plcNYSE: MDT | $118.91B | $92.86 | -0.04% |
| EssilorLuxottica Société anonymeENXTPA: EL | $86.72B | €160.25 | -0.90% |
| Boston Scientific CorporationNYSE: BSX | $71.03B | $49.17 | +0.33% |
| Siemens Healthineers AGXTRA: SHL | $52.46B | €39.95 | -1.09% |
| HOYA CorporationTSE: 7741 | $52.35B | ¥24,895.00 | -1.37% |
Figures last refreshed Aug 18, 2026.